HomeGeneticsConditionXia-Gibbs syndrome
Back to Condition
Xia-Gibbs syndrome
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Xia-Gibbs syndrome

Xia-Gibbs syndrome is a neurological disorder characterized by weak muscle tone, mild to severe intellectual disability, and delayed development, resulting from variants in the AHDC1 gene.

Overview

Xia-Gibbs syndrome is a neurological disorder characterized by weak muscle tone (hypotonia), mild to severe intellectual disability and delayed development. Expressive language skills (vocabulary and the production of speech) are particularly affected; children with this condition usually do not speak their first word, a milestone typically achieved within the first year, until age two or later, and some never learn to talk. Development of motor skills, such as crawling and walking, can also be delayed.

Symptoms

Other signs and symptoms of Xia-Gibbs syndrome vary among affected individuals. Additional neurological features include poor coordination and balance (ataxia) and seizures. Feeding problems and sleep abnormalities can also occur in people with the condition, and many affected individuals experience short pauses in breathing while they sleep (obstructive sleep apnea). In some people with Xia-Gibbs syndrome, imaging tests of the brain show abnormalities in the brain's structure. For example, the tissue connecting the left and right halves of the brain (the corpus callosum) can be abnormally thin.

Xia-Gibbs syndrome can also affect physical development. Growth is usually impaired, and many affected individuals are shorter than their peers. Side-to-side curvature of the spine (scoliosis) is also a common feature. Some people with Xia-Gibbs syndrome have unusual facial features, such as a broad nasal bridge, low-set ears or epicanthal folds, widely spaced eyes (hypertelorism), eye openings that slant up or down (upslanting palpebral fissures or downslanting palpebral fissures), a flat bridge of the nose, or a pointed chin. Other, less-common abnormalities involving the bones and skin include premature fusion of certain skull bones (craniosynostosis), unusually loose (lax) joints, and loose skin.

Neurodevelopmental disorders can also occur in Xia-Gibbs syndrome. Some affected individuals have autism spectrum disorder, which is characterized by impaired communication and social interactions, or attention-deficit/hyperactivity disorder (ADHD). Other problems can include aggression, anxiety, poor impulse control, and self-injury.

Frequency

Xia-Gibbs syndrome is thought to be a rare disorder, although its prevalence is unknown. Doctors believe the condition is underdiagnosed, because many people with intellectual disability never have genetic testing to determine the underlying cause.

Causes & Risk Factors

Xia-Gibbs syndrome is caused by variants (also known as mutations) in a gene called AHDC1. This gene provides instructions for making a protein with an unknown function. Researchers suspect that the protein may be able to attach (bind) to DNA and control the activity of other genes. Most of the AHDC1 gene variants involved in Xia-Gibbs syndrome lead to production of abnormally short AHDC1 proteins. The effects of these changes in cells are unclear. The shortened proteins may be quickly broken down or be unable to function. Or, the abnormal proteins may interfere with the function of AHDC1 proteins produced from the normal copy of the gene. Researchers suspect that a reduction in the amount of functional AHDC1 protein impairs normal brain development, leading to intellectual disability, speech problems, and other neurological features of Xia-Gibbs syndrome. Abnormal development of other body systems caused by a shortage of AHDC1 protein may account for additional signs and symptoms of the condition.

Learn more about the gene associated with Xia-Gibbs syndrome

  • AHDC1

Inheritance

Xia-Gibbs syndrome is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

The condition results from new (de novo) variants in the gene that occur either during the formation of reproductive cells (eggs or sperm) in an affected individual’s parent or in early embryonic development. Affected individuals have no history of the disorder in their family.

Other Names for This Condition

    Frequently Asked Questions

    Early intervention with speech‑language therapy, occupational therapy, and physical therapy is crucial. Structured play that encourages fine motor skills and balance exercises can improve coordination. For severe hypotonia, a multidisciplinary team may consider neuromuscular electrical stimulation or specialized equipment like tilt tables. Regular assessment by a developmental pediatrician helps adjust the therapy plan.
    Confirmation requires sequencing of the AHDC1 gene to identify pathogenic variants. The test is usually performed on a blood sample using next‑generation sequencing panels for neurodevelopmental disorders. Results are interpreted by a clinical geneticist, and a variant of uncertain significance may require additional functional studies or family segregation analysis.
    Routine overnight polysomnography is recommended to detect obstructive sleep apnea, which may require continuous positive airway pressure (CPAP) therapy. Seizure monitoring includes EEG and seizure diaries; antiepileptic drugs should be chosen based on seizure type and side‑effect profile. Caregivers should also ensure a safe sleep environment, avoid overheating, and keep a consistent bedtime routine to reduce apnea episodes.
    Parents should watch for delays in reaching speech milestones (first word after 12 months), motor skills such as crawling or walking beyond 18 months, and signs of hypotonia (e.g., poor head control or floppy limbs). Feeding difficulties, frequent pauses in breathing during sleep, and unusual facial features (broad nasal bridge, low‑set ears) can also raise suspicion and warrant early evaluation.
    Source: MedlinePlus, National Library of Medicine

    MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

    Meyahealth

    Ⓒ 2026. All rights reserved by MEYA